Andrea Squeri

Messina, 98122, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?

Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: Are we on the right path?

Journal: Critical reviews in oncology/hematology
Published: February 14, 2024

Surgical De-Escalation for Re-Excision in Patients with a Margin Less Than 2 mm and a Diagnosis of DCIS.

Surgical De-Escalation for Re-Excision in Patients with a Margin Less Than 2 mm and a Diagnosis of DCIS.

Journal: Cancers
Published: January 21, 2024

Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy.

Rates of Primary and Secondary Prevention of Cervical Cancer: A Study in a Province in the South of Italy.

Journal: Vaccines
Published: September 01, 2023

Therapeutic strategies for HER2-positive breast cancer with central nervous system involvement: a literature review and future perspectives.

Therapeutic strategies for HER2-positive breast cancer with central nervous system involvement: a literature review and future perspectives.

Journal: Translational cancer research
Published: July 03, 2023

Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?

Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?

Journal: International journal of molecular sciences
Published: May 20, 2023

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives.

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives.

Journal: Current oncology (Toronto, Ont.)
Published: March 05, 2023

Enfortumab Vedotin in metastatic bladder cancer: a case report of durable clinical efficacy in a pretreated patient.

Enfortumab Vedotin in metastatic bladder cancer: a case report of durable clinical efficacy in a pretreated patient.

Journal: Acta bio-medica : Atenei Parmensis
Published: December 26, 2022

Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review.

Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review.

Journal: Translational lung cancer research
Published: September 03, 2022

Reactogenicity and Humoral Immune Response after Heterologous Vaxzevria/Comirnaty Vaccination in a Group of Individuals Vaccinated in the AOU Policlinic "G. Martino" (Messina, Italy): A Retrospective Cohort Study.

Reactogenicity and Humoral Immune Response after Heterologous Vaxzevria/Comirnaty Vaccination in a Group of Individuals Vaccinated in the AOU Policlinic "G. Martino" (Messina, Italy): A Retrospective Cohort Study.

Journal: Vaccines
Published: July 19, 2022

Correct management and low rate of contagiousness of healthcare workers in a University Hospital in Southern Italy: from contact tracing to serological investigation.

Correct management and low rate of contagiousness of healthcare workers in a University Hospital in Southern Italy: from contact tracing to serological investigation.

Journal: Acta bio-medica : Atenei Parmensis
Published: July 01, 2020

Molecular epidemiology of antimicrobial resistant microorganisms in the 21th century: a review of the literature.

Molecular epidemiology of antimicrobial resistant microorganisms in the 21th century: a review of the literature.

Journal: Acta bio-medica : Atenei Parmensis
Published: January 15, 2020
Showing 1-11 of 11

Last Updated: 09/26/2026